Medesis Pharma SA (ALMDP) — Strategic Asset Allocation Index
Medesis Pharma SA (ALMDP) has a Strategic Asset Allocation Index of 4.0% as of December 2021. Strategic assets (PP&E of €65.83K plus long-term investments of €-) total €65.83K, measured against net assets of €1.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Medesis Pharma SA Strategic Asset Allocation Index (2021–2021)
This chart shows how Medesis Pharma SA's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the index stands at 4.0%, representing strategic assets of €65.83K against net assets of €1.65 Million EUR. Explore cash flow conversion of Medesis Pharma SA to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Medesis Pharma SA (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Medesis Pharma SA from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Medesis Pharma SA (ALMDP) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 4.0% | €65.83K | €65.83K | €- | €1.65 Million | — |